ASX - By Stock
|
NTU |
Re:
Ann: Cyber security breach
|
|
Bouncing
|
16 |
5.1K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
16
|
5.1K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
Bouncing
|
62 |
16K |
0 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
62
|
16K
|
0
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
Bouncing
|
197 |
78K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
197
|
78K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Bouncing
|
85 |
20K |
7 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Bouncing
|
223 |
54K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
223
|
54K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Bouncing
|
10K |
4.8M |
22 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
22
|
|
ASX - By Stock
|
COV |
Re:
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
|
|
Bouncing
|
47 |
11K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
47
|
11K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
Bouncing
|
160 |
80K |
10 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
80K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
Bouncing
|
41 |
8.5K |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
41
|
8.5K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Bouncing
|
231 |
120K |
20 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
231
|
120K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Bouncing
|
231 |
120K |
17 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
120K
|
17
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
Bouncing
|
36 |
8.3K |
3 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
36
|
8.3K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
Bouncing
|
36 |
8.3K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
36
|
8.3K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Bouncing
|
1.0K |
537K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
1.0K
|
537K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Bouncing
|
510 |
117K |
5 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
510
|
117K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren CEO to present at BIO & Jefferies conferences in US
|
|
Bouncing
|
10 |
5.7K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
10
|
5.7K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Bouncing
|
1.0K |
537K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.0K
|
537K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Resignation of CEO and Managing Director
|
|
Bouncing
|
61 |
21K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
61
|
21K
|
1
|
|
ASX - By Stock
|
EVE |
Re:
Ann: Sale of Jendale Property
|
|
Bouncing
|
10 |
1.6K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
10
|
1.6K
|
2
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
Bouncing
|
11 |
2.6K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
11
|
2.6K
|
0
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
Bouncing
|
11 |
2.6K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
11
|
2.6K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Bouncing
|
10K |
4.8M |
12 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10K
|
4.8M
|
12
|
|
ASX - By Stock
|
AZI |
Re:
Ann: Lazio Lithium Project Maiden Mineral Resource Estimate
|
|
Bouncing
|
2 |
1.0K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Bouncing
|
37 |
9.4K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.4K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance
|
|
Bouncing
|
163 |
66K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
163
|
66K
|
2
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
Bouncing
|
3.0K |
899K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
3.0K
|
899K
|
0
|
|
ASX - By Stock
|
PIL |
Re:
Daily Price Movement / General Discussion
|
|
Bouncing
|
3.0K |
899K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
3.0K
|
899K
|
3
|
|
ASX - By Stock
|
PIL |
Re:
Ann: More technical integration contracts with Strategic Partners
|
|
Bouncing
|
21 |
5.7K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
21
|
5.7K
|
0
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Bouncing
|
38K |
17M |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
38K
|
17M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Bouncing
|
10K |
4.8M |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
10K
|
4.8M
|
0
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Talius Group enters MSA with Hato Hone St John
|
|
Bouncing
|
4 |
1.6K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
4
|
1.6K
|
2
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Talius Group enters MSA with Hato Hone St John
|
|
Bouncing
|
4 |
1.6K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
4
|
1.6K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bouncing
|
1.4K |
359K |
10 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.4K
|
359K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bouncing
|
1.4K |
359K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.4K
|
359K
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Bouncing
|
38K |
17M |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
38K
|
17M
|
7
|
|
ASX - By Stock
|
WWG |
Re:
Ann: 1H24 Results Presentation
|
|
Bouncing
|
6 |
3.0K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
6
|
3.0K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Bouncing
|
316 |
163K |
24 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
163K
|
24
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVE
|
|
Bouncing
|
22 |
8.5K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
22
|
8.5K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVE
|
|
Bouncing
|
22 |
8.5K |
7 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
22
|
8.5K
|
7
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Talius Group Start of 2024 Update
|
|
Bouncing
|
2 |
1.2K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
2
|
1.2K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to present at Biotech Showcase at JPM week
|
|
Bouncing
|
19 |
7.2K |
1 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
19
|
7.2K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Bouncing
|
10K |
4.8M |
9 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
10K
|
4.8M
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: ADVENT-AML clinical trial GMP manufacturing complete
|
|
Bouncing
|
8 |
4.0K |
7 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
8
|
4.0K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Bouncing
|
210 |
88K |
28 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
88K
|
28
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1B ADVENT-AML trial to be presented at ASH meeting
|
|
Bouncing
|
7 |
3.0K |
3 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
7
|
3.0K
|
3
|
|
ASX - By Stock
|
TAL |
Re:
Ann: Talius Group Completes $2.5 Million Placement
|
|
Bouncing
|
4 |
1.9K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Completion of Entitlement Offer
|
|
Bouncing
|
44 |
12K |
4 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
44
|
12K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
PCK Chart
|
|
Bouncing
|
89 |
35K |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
89
|
35K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Bouncing
|
10K |
4.8M |
5 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
10K
|
4.8M
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $10 million
|
|
Bouncing
|
99 |
32K |
3 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
99
|
32K
|
3
|
|